Asahi Kasei Kuraray Medical Co.,Ltd. Sustainability Profile
Asahi Kasei Kuraray Medical Co., Ltd., a prominent player in the medical device industry, is headquartered in Japan. Established in 2001, the company has rapidly evolved, focusing on innovative healthcare solutions that enhance patient outcomes. With a strong presence in Asia and expanding operations globally, Asahi Kasei Kuraray Medical is renowned for its advanced medical technologies, particularly in the fields of dialysis and blood purification. The company’s core products, including high-performance dialysers and blood filtration systems, are distinguished by their cutting-edge design and superior biocompatibility. Asahi Kasei Kuraray Medical has achieved significant milestones, positioning itself as a leader in the medical sector, committed to improving the quality of life for patients worldwide. With a dedication to research and development, the company continues to set benchmarks in medical innovation.
DitchCarbon Score
How does Asahi Kasei Kuraray Medical Co.,Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Asahi Kasei Kuraray Medical Co.,Ltd.'s score of 70 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Asahi Kasei Kuraray Medical Co., Ltd., headquartered in Japan (JP), currently does not have specific carbon emissions data available for the most recent year. The company is part of a corporate family that includes Asahi Kasei Corporation, from which it inherits emissions data and climate commitments. Asahi Kasei Corporation has engaged in various climate initiatives, including participation in the Carbon Disclosure Project (CDP), which reflects a commitment to transparency in environmental impact. However, specific reduction targets or achievements for Asahi Kasei Kuraray Medical Co., Ltd. have not been disclosed. The absence of detailed emissions data and specific reduction initiatives indicates that the company may still be in the process of establishing its own climate commitments or may rely on broader corporate strategies from its parent company. Asahi Kasei Corporation's overarching climate strategies may influence the subsidiary's future commitments and performance in carbon emissions reduction.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | 0,000,000,000 | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | - | 0,000,000,000 | - | - | - | - | - | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 0,000,000,000 | 0,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is Asahi Kasei Kuraray Medical Co.,Ltd.'s Industry?
How Carbon Intensive is Asahi Kasei Kuraray Medical Co.,Ltd.'s Location?
Asahi Kasei Kuraray Medical Co.,Ltd.'s Scope 3 Categories Breakdown
Asahi Kasei Kuraray Medical Co.,Ltd.'s Scope 3 emissions, which decreased by 0% last year and increased by approximately 113% since 2015, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 79% of total emissions under the GHG Protocol, with "End-of-Life Treatment of Sold Products" being the largest emissions source at 41% of Scope 3 emissions.
Top Scope 3 Categories
Asahi Kasei Kuraray Medical Co.,Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Asahi Kasei Kuraray Medical Co.,Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
